Fig. 2: Best overall response rate based on subgroup. | Leukemia

Fig. 2: Best overall response rate based on subgroup.

From: Long-term activity of tandem CD19/CD20 CAR therapy in refractory/relapsed B-cell lymphoma: a single-arm, phase 1–2 trial

Fig. 2: Best overall response rate based on subgroup.

ASCT autologous stem cell transplantation, CAR chimeric antigen receptor, CI confidence interval, DLBCL diffuse large B-cell lymphoma, ECOG Eastern Cooperative Oncology Group, FL follicular lymphoma, PMBCL primary mediastinal B-cell lymphoma, SPD sum of the product of the diameters, tFL transformed follicular lymphoma.

Back to article page